ESAIY
Price:
$6.68
Market Cap:
$1.18T
Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan. It offers Dayvigo, for the treatment of insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; Methycobal for the treatment of peripheral neuropathy; and Halaven, an anticancer agent for the treatment of breast cancer. The company also provides Jyseleca, a janus kinase inhibitor; Elental, a branched-chain amino acid preparation; Goofice and Movicol for chronic constipation; Fycompa, an antiepileptic agent; Pariet, a proton-pump inhibitor...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2023-02-02
Stock Exchange
PNK
Ticker
ESAIY
According to Eisai Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 29.04. This represents a change of -69.12% compared to the average of 94.04 of the last 4 quarters.
The mean historical PE Ratio of Eisai Co., Ltd. over the last ten years is 38.30. The current 29.04 PE Ratio has changed 7.48% with respect to the historical average. Over the past ten years (40 quarters), ESAIY's PE Ratio was at its highest in in the September 2020 quarter at 501.21. The PE Ratio was at its lowest in in the March 2021 quarter at -174.40.
Average
38.30
Median
38.17
Minimum
18.66
Maximum
56.59
Discovering the peaks and valleys of Eisai Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 171.68%
Maximum Annual PE Ratio = 56.59
Minimum Annual Increase = -37.55%
Minimum Annual PE Ratio = 18.66
Year | PE Ratio | Change |
---|---|---|
2024 | 41.11 | 5.91% |
2023 | 38.82 | 14.52% |
2022 | 33.90 | -33.14% |
2021 | 50.70 | 171.68% |
2020 | 18.66 | -34.29% |
2019 | 28.40 | -24.29% |
2018 | 37.51 | -10.69% |
2017 | 42.00 | 18.83% |
2016 | 35.34 | -37.55% |
2015 | 56.59 | 61.84% |
The current PE Ratio of Eisai Co., Ltd. (ESAIY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
37.94
5-year avg
36.64
10-year avg
38.30
Eisai Co., Ltd.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eisai Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Eisai Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Eisai Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Eisai Co., Ltd. (ESAIY)?
What is the highest PE Ratio for Eisai Co., Ltd. (ESAIY)?
What is the 3-year average PE Ratio for Eisai Co., Ltd. (ESAIY)?
What is the 5-year average PE Ratio for Eisai Co., Ltd. (ESAIY)?
How does the current PE Ratio for Eisai Co., Ltd. (ESAIY) compare to its historical average?